J&J Duragesic Patent Upheld; Pediatric Exclusivity Dispute Will Determine Timing Of Mylan Generic

Mylan claims it should be able to launch in July; J&J says the generic is blocked by pediatric exclusivity until January 2005. Mylan says J&J failed to sue within statutory 45-day period and so forfeits pediatric exclusivity protection.